A detailed history of Sherbrooke Park Advisers LLC transactions in Accolade, Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 104,938 shares of ACCD stock, worth $389,319. This represents 0.09% of its overall portfolio holdings.

Number of Shares
104,938
Previous 59,194 77.28%
Holding current value
$389,319
Previous $212 Million 90.65%
% of portfolio
0.09%
Previous 0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.4 - $4.42 $155,529 - $202,188
45,744 Added 77.28%
104,938 $404 Million
Q2 2024

Aug 14, 2024

BUY
$3.58 - $10.13 $173,379 - $490,595
48,430 Added 449.93%
59,194 $212 Million
Q1 2024

May 15, 2024

BUY
$9.22 - $15.02 $99,244 - $161,675
10,764 New
10,764 $113 Million

Others Institutions Holding ACCD

About Accolade, Inc.


  • Ticker ACCD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 71,938,896
  • Market Cap $267M
  • Description
  • Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and cli...
More about ACCD
Track This Portfolio

Track Sherbrooke Park Advisers LLC Portfolio

Follow Sherbrooke Park Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sherbrooke Park Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sherbrooke Park Advisers LLC with notifications on news.